Company · Private
Junevity
Develops siRNA therapeutics designed to reset dysregulated transcriptional networks in aged cells back toward a youthful state, using its RESET discovery platform.
Listing
Private
Ticker
—
Headquarters
South San Francisco, US
Founded
2023
Technology
siRNA transcriptional reset
Category
Longevity thesis
Because transcriptional drift is a core feature of aging, silencing the master regulators of that drift with well-understood siRNA chemistry could reset cell state with a validated modality.
Programmes
- RESET platform (siRNA)Preclinical
Transcriptional cell reset
Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.